Literature DB >> 16758425

Genetic screening to prevent abacavir hypersensitivity reaction: are we there yet?

Elizabeth J Phillips.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16758425     DOI： 10.1086/504878

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  11 in total

1.  Brief Report: Should Abacavir Be a First-Line Alternative for Adults With HIV in Sub-Saharan Africa?

Authors:  Guinevere Q Lee; Suzanne McCluskey; Yap Boum; Peter W Hunt; Jeffrey N Martin; David R Bangsberg; Xiaojiang Gao; P Richard Harrigan; Jessica E Haberer; Mark J Siedner
Journal:  J Acquir Immune Defic Syndr       Date:  2017-10-01       Impact factor: 3.731

2.  The cost-effectiveness of HLA-B*5701 genetic screening to guide initial antiretroviral therapy for HIV.

Authors:  Bruce R Schackman; Callie A Scott; Rochelle P Walensky; Elena Losina; Kenneth A Freedberg; Paul E Sax
Journal:  AIDS       Date:  2008-10-01       Impact factor: 4.177

Review 3.  Successful translation of pharmacogenetics into the clinic: the abacavir example.

Authors:  Elizabeth Phillips; Simon Mallal
Journal:  Mol Diagn Ther       Date:  2009       Impact factor: 4.074

4.  Perceptions of genetic testing and genomic medicine among drug users.

Authors:  David C Perlman; Camila Gelpí-Acosta; Samuel R Friedman; Ashly E Jordan; Holly Hagan
Journal:  Int J Drug Policy       Date:  2014-06-24

5.  Clinical Abacavir Hypersensitivity Reaction among Children in India.

Authors:  Jaya Chakravarty; Saurabh Sharma; Anuradha Johri; Ankita Chourasia; Shyam Sundar
Journal:  Indian J Pediatr       Date:  2016-02-18       Impact factor: 1.967

6.  NEW STRATEGIES TO PREDICT AND PREVENT SERIOUS IMMUNOLOGICALLY MEDIATED ADVERSE DRUG REACTIONS.

Authors:  Elizabeth J Phillips
Journal:  Trans Am Clin Climatol Assoc       Date:  2018

7.  Prevalence of HLA-B*5701 and Its Relationship with Abacavir Hypersensitivity Reaction in Iranian HIV-Infected Patients.

Authors:  Shadi Baniasadi; Shokoufeh Baradaran Shokouhi; Payam Tabarsi; Maryam Alehashem; Hossein Khalili; Fanak Fahimi; Seyed Alireza Nadji
Journal:  Tanaffos       Date:  2016

8.  Low prevalence of human leukocyte antigen-B*5701 in HIV-1-infected Chinese subjects: a prospective epidemiological investigation.

Authors:  Hongwei Zhang; Tong Zhang; Hongxin Zhao; Ning Han; Haiwei Zhou; Yun He; Qingxia Zhao; Hong Li; Huiqin Li; Mi Zhang; Jianjian Li; Yongtao Sun; Ke Zhao; Qing Liu; Zhiying Liu; Zhen Li; Wei Xia; Yun Lan; Haolan Hu; Weiping Cai; Hao Wu
Journal:  AIDS Res Ther       Date:  2015-08-19       Impact factor: 2.250

9.  The use of pharmacogenetics in clinical practice for the treatment of individuals with HIV infection in Thailand.

Authors:  Asalaysa Bushyakanist; Apichaya Puangpetch; Chonlaphat Sukasem; Sasisopin Kiertiburanakul
Journal:  Pharmgenomics Pers Med       Date:  2015-11-05

10.  Safety and Efficacy of Ziagen (Abacavir Sulfate) in HIV-Infected Korean Patients.

Authors:  Heawon Ann; Ki Hyon Kim; Hyun Young Choi; Hyun Ha Chang; Sang Hoon Han; Kye Hyung Kim; Jin Soo Lee; Yeon Sook Kim; Kyung Hwa Park; Young Keun Kim; Jang Wook Sohn; Na Ra Yun; Chang Seop Lee; Young Wha Choi; Yil Seob Lee; Shin Woo Kim
Journal:  Infect Chemother       Date:  2017-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.